ICOP India 2025 - Highlights
ICOP India 2025 brought together a global community of scientists, researchers, and innovators in the field of pharmacometrics.
The conference featured groundbreaking sessions, collaborative workshops, and vibrant community engagement across four dynamic days.
ICOP 2025 - Participation Figures
ICOP 2025 Speakers & Topics
Dr. Joga Gobburu
Centre for Translational Medicine, University of Maryland, MD, USA
Dr. Mathangi Gopalakrishnan
Associate Professor, University of Maryland, MD, USA
Strategic Integration of Model-Informed Approaches in 505(b)(2) Drug Development
Mr. Sivacharan Kollipara
Head, Biopharmaceutics, Dr. Reddy’s Laboratories Ltd, Hyderabad, India
Applications of modeling and simulations in generic product development: Case studies and regulatory perspectives
Dr. Vikram Gota
Professor, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Mumbai
Dose optimization in oncology
Dr. Richard Hoglund
Head, Pharmacometrics research group, Department of Clinical Pharmacology, Mahidol-Oxford Research Unit, Bangkok, Thailand.
Pharmacometric approaches to assess ultra-short response-guided treatment in Hepatitis C
Dr. Thanaporn Wattanakul
Scientist & Deputy Head of Pharmacometrics at Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
A pharmacometrics approach to assess drug exposures in lactating women and breastfed infants
Dr. Blessed Winston Arul Dhas
Professor, Christian Medical College, Vellore
Intravenous doxycycline, azithromycin, or both for severe scrub typhus
Dr. Ayorinde Adehin
Scientist in Pharmacometrics, MORU, University of Oxford
Pre-referral rectal artesunate in children with severe malaria: any benefit?
Dr. Nusrat Shafiq
Professor, Clinical Pharmacology Unit, Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh
Pharmacometrics approach for dose optimization of anti-bacterial in special populations
Dr. Liang Zhao
Professor, University of California San Francisco, CA, USA Former Director, Division of Quantitative methods and Modeling, USFDA
Leveraging Model Integrated Evidence for Drug Development and Approval
Dr. Joga Gobburu
Centre for Translational Medicine, University of Maryland, MD, USA
Modeling and Simulation: Ek Soch hai
Dr. Yasvanth Ashokraj
Director, Biopharmaceutics and Pharmacokinetics, CIPLA, Mumbai
Application of Model based Bioequivalence: A perspective for Generic Drug Industry
Recap
The 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗼𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗺𝗲𝘁𝗿𝗶𝗰𝘀 𝗜𝗻𝗱𝗶𝗮 (𝗜𝗖𝗢𝗣 𝟮𝟬𝟮𝟱) was a tremendous success, bringing together global thought leaders in drug development, clinical pharmacology, and healthcare data analytics. The event, hosted by 𝗦𝗢𝗣𝗛𝗔𝗦 in collaboration with International Society of Pharmacometrics , Manipal Academy of Higher Education, and Manipal College of Pharmaceutical Sciences (MCOPS), Manipal, has further solidified our commitment to driving innovation in quantitative sciences.
This year’s sessions focused on cutting-edge topics such as:
🔹 505(b)(2) Submissions
🔹 Generic Drug Development
🔹 Clinical Pharmacometrics Applications
SOPHAS continues to be at the forefront of advancing pharmacometrics, clinical pharmacology, and healthcare data analytics, with a mission to empower professionals globally. As we embrace emerging fields like machine learning applications, we remain committed to providing top-notch education and fostering collaboration across academia, industry, and regulatory bodies.
The energy, learning, and networking at ICOP 2025 have only reinforced the importance of this platform in the advancement of model-informed drug development. The journey doesn’t end here – stay tuned as we continue to develop impactful training programs, research initiatives, and global partnerships.
Gala Night
The Gala Night was a vibrant conclusion to ICOP 2025, featuring cultural performances, and a night of celebration with our community of scientists and students.
Important Dates
October 01, 2024
January 05, 2025
December 25, 2024
January 15, 2025
January 30 & 31, 2025
February 01 & 02, 2025
Sponsors
Diamond Partner
Gold Partner
Join us for ICOP India 2026
Registrations Opening Soon!
Registration Fee Details
Indian Registrations ( INR )
|
|
Early Bird (Till Dec 24 2024)
|
Late Registration (Dec 25 to Jan 15)
|
|---|---|---|
|
Students/Trainees
|
6000
|
7000
|
|
Academia
|
7000
|
8000
|
|
Industry
|
12000
|
14000
|
International Registrations ( USD )
|
|
Early Bird (Till Dec 24 2024)
|
Late Registration (Dec 25 to Jan 15)
|
|---|---|---|
|
Students/Trainees
|
125
|
150
|
|
Academia
|
150
|
200
|
|
Industry
|
250
|
300
|
Pre-conference workshop during ICOP-India 2025
Accommodation Details
ICOP 2025 Abstract Submission Guidelines
Original research work from following areas will be accepted
- Quantitative approaches in drug development
- PKPD models
- Clinical Pharmacometrics
- Methodological studies
- PBPK modeling for drug drug interactions
- PBBM absorption modeling
- Bioequivalence risk assessments using modeling approaches
- Biostudy waivers using novel modeling approaches
Author:
Please provide information on all the authors with their affiliations and email id for corresponding author. The presenting author should be underlined. The same author list will appear in the abstract book.
Language:
All abstracts must be in English
Abstract Body:
The work published in previous national or international meetings or journals will not be accepted. The abstract should contain the statement on hypothesis or objective, the methods used, results and conclusion. The font of text should be Times New Roman with 12 font size. Abstract text should be typed single-spaced and with maximum 300 words. Type the text as one paragraph. All references included in the abstract should be numbered and accompanied by the full citation, including authors names, title, journal name, volume, number, inclusive paging, and year of publication